×
Shopping Cart
×
Quote List
0Quotes
0Cart

Clipos™ Anti-BCMA/CD3 bispecific mRNA Lipid Nanoparticles

Catalog:CDL23-081-L

Unit Size
Price
$1595

Buy Now Need technical support? Datasheet

Specifications QA & Reviews
StorageStore at 4°C
DescriptionBCMA (B cell maturation antigen), also known as CD269, TNFRSF-17, is an ideal target antigen for novel multiple myeloma therapy due to its highly selective expression in malignant plasma cells. BCMA is a cell surface receptor of the TNF receptor superfamily that recognizes B cell activators and is encoded by the human TNFRSF17 gene. This receptor is preferentially expressed on mature B lymphocytes and is important for B cell development and autoimmune responses. This receptor has been shown to specifically bind tumor necrosis factor (ligand) superfamily member 13b (TNFSF13B/TALL-1/BAFF), thereby activating NF-κB and MAPK8/JNK. For targeting BCMA, chimeric antigen receptor (CAR)-modified T-cell therapy is one of the most common treatment modalities. Interleukin-15 (IL-15), encoded by the IL15 gene, is a member of the four α-helix bundle family of cytokines. Like IL-2, IL-15 binds to and signals through a complex consisting of the IL-2/IL-15 receptor beta chain (CD122) and common gamma chains (γ-C, CD132). IL-15 regulates the activation and proliferation of T cells and natural killer (NK) cells. As an inhibitor of the apoptotic pathway, IL-15 inhibits T lymphocyte apoptosis by inducing Bcl-2 and/or Bcl-xL. In preclinical models, IL-15 has been shown to enhance antitumor immunity of CD8+ T cells. This product is designed as a tool for the delivery and expression of anti-BCMA/CD3 mutant Fc mRNA for research. The product leverages the lipid nanoparticle (LNP) technology platform for simple and efficient delivery of anti-BCMA/CD3 mutant Fc mRNA to a variety of mammalian cells in vitro and in vivo. The LNPs used are formulated with SM-102, DSPC, cholesterol and DMG-PEG2000 at an optimal molar concentration for a high rate of encapsulation and efficient mRNA delivery. The anti-BCMA/CD3 mutant Fc in this product is approximately 70 kD and consists of anti-BCMA scFv (single-chain variable fragment), mutant human Fc and CD3ze signaling domains
Lipid compositionSM-102/DSPC/Cholesterol/DMG-PEG2000
Technical NotesWork with mRNA-LNP on ice. It is important to minimize the time that the product spends at room temperature; after handling product during experiments, return immediately to ice.Upon receiving product, briefly pulse spin before opening to ensure product is at bottom of container; it is important not to spin for too long as this may rupture mRNA-LNP’s. Do not vortex. mRNA-LNP products should only be handled with certified RNAase-free reagents and consumables; use of filtered pipette tips is highly recommended
Encoding mRNATNFRSF17
In Vitro QC (Cell Types)HEK293S
Technology ApplicationsAntibody research
My Review for Clipos™ Anti-BCMA/CD3 bispecific mRNA Lipid Nanoparticles

Required fields are marked with *

Overall Rating *
×
Related Products
Product Name Catalog Lipid composition Liposome Size Price
Clipos™ Anti-BCMA/CD3 bispecific mRNA Lipid Nanoparticles CDL23-095-L SM-102/DSPC/Cholesterol/DMG-PEG2000 $1328
Clipos™ Anti-BCMA/CD3 bispecific mRNA Lipid Nanoparticles CDL23-077-L SM-102/DSPC/Cholesterol/DMG-PEG2000 $1595
Clipos™ Anti-BCMA/CD3 bispecific mRNA Lipid Nanoparticles CDPM08 SM-102/DSPC/cholesterol/DMG-PEG2000 INQUIRY
Clipos™ Anti-BCMA/CD3 bispecific mRNA Lipid Nanoparticles CDL23-063-L SM-102/DSPC/Cholesterol/DMG-PEG2000 $1595
Clipos™ Anti-BCMA/CD3 bispecific mRNA Lipid Nanoparticles CDL23-079-L SM-102/DSPC/Cholesterol/DMG-PEG2000 $1595
Clipos™ Anti-BCMA/CD3 bispecific mRNA Lipid Nanoparticles CDL23-011-L SM-102/DSPC/Cholesterol/DMG-PEG2000 $1595
Clipos™ Anti-BCMA/CD3 bispecific mRNA Lipid Nanoparticles CDL23-087-L SM-102/DSPC/Cholesterol/DMG-PEG2000 $1595
Clipos™ Anti-BCMA/CD3 bispecific mRNA Lipid Nanoparticles CDL23-073-L SM-102/DSPC/Cholesterol/DMG-PEG2000 $1595
Products
Fill out the form below
to receive a quote

GET A QUOTE

Services

Drug Targeting Strategy

Drug Delivery Nanoparticles Formulation

Bioparticles Analysis and Characterization

Bioactive Particles & Fillers Production

Functional Biomedical Coatings

Lipid Library Development for Drug Delivery

Aptamer Targeted Drug Delivery System

Other Types of Drug Delivery

Products

Liposome System

Chelating Agents

Bioactive Matrixes

Porous Organic Materials

Biopolymers & Synthetic Polymers

PROTAC

Transfection

Exosome Products

Cleavable Linkers

Pharmaceutical Excipients (drug/medical grade)

Tissue Engineering Scaffold

  • (USA)
  • (Europe)
Cookie Policy | Privacy Policy | Copyright © CD Bioparticles. All rights reserved.
×
Upload products to cart

1. Download the template.

2. Enter product information on the template (maximum number of products: 200).

3. Load the file using selector below.

Drag and drop your file here or

Choose file
*.xlsx (max 20 MB)

4. Click the "Add to cart" button.

×
Upload products to quote list

1. Download the template.

2. Enter product information on the template (maximum number of products: 200).

3. Load the file using selector below.

Drag and drop your file here or

Choose file
*.xlsx (max 20 MB)

4. Click the "Add to quote" button.